Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG (T3 Pharma), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF. T3 Pharma has …
Read Full Story at source (may require registration)
Las Vegas, CA, April 19, 2025 (GLOBE NEWSWIRE) -- Online real money casinos are hard…
A new study predicts that Bitcoin could hit $1 million as early as 2027 as…
In a notable shift in market dynamics, the latest data from the Commodity Futures Trading…
In a notable development for the agricultural commodities market, the U.S. Commodity Futures Trading Commission…
In the latest market activity, speculative positions in the New Zealand Dollar (NZD) have shown…
In a recent update from the Commodity Futures Trading Commission (CFTC), the Japanese Yen (JPY)…
This website uses cookies.